Skip to main content
WELLWelltower Inc.Sell5.9·$227.20
WELL · Why this verdict

Why Welltower (WELL) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score5.9/10
ConfidenceMEDIUM
MacroRISK_OFF
TrendMatrix Research · core thesis

Engine thesis — one sentence

Welltower is the industry growth leader in healthcare real estate with 38% year-over-year revenue growth and excellent cash conversion, but heavy concentration in seniors housing operating (78% of revenue) and a price that has reached analyst targets leave little margin of safety.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

With 78% of revenue derived from seniors housing operating, Welltower's financial performance is tightly linked to a single product segment, creating vulnerability to any sector-specific headwinds such as occupancy declines or operating cost increases.

↓Deteriorating
Bear case
Expectation
Revenue concentration from seniors housing operating stays below 80% over the next 12 months as the portfolio diversifies, and same-store revenue growth in this segment exceeds 5%.

CounterHigh concentration in a single segment can also mean operational focus and scale advantages; if seniors housing operating continues its strong trajectory, concentration amplifies upside.

Welltower delivered 38% year-over-year revenue growth and ranks as the industry growth leader among peers, suggesting the portfolio is benefiting from demographic tailwinds and strong occupancy recovery.

↓Deteriorating
Growth breakdown
Expectation
Revenue growth remains above 15% year-over-year for the next 2 reported quarters, maintaining the company's industry-leading growth ranking.

CounterGrowth at this rate may reflect post-pandemic occupancy recovery that is now maturing; sustaining 38% growth is unlikely, and a deceleration could disappoint investors pricing in continued acceleration.

Free cash flow equals 185% of net income, indicating that the business generates substantially more cash than GAAP earnings show, which supports dividend sustainability and capital reinvestment capacity.

↑Improving
Quality breakdown
Expectation
Free cash flow as a percentage of net income remains above 100% for the next 2 reported annual periods, confirming durable cash generation above reported earnings.

CounterREIT cash conversion ratios can be inflated by depreciation add-backs; the 185% ratio may reflect accounting treatment rather than genuine operational cash generation advantage.

At a current price of $212.82, Welltower trades just $0.26 below the analyst consensus target of $213.08, leaving 0.1% upside versus 5.9% downside to the stop-loss — a reward-to-risk ratio of 0.02 that makes new entry unattractive.

↓Deteriorating
Targets
Expectation
Analyst price targets are raised by at least 10% above the current price within the next 6 months to restore meaningful upside potential.

CounterHigh-quality growing REITs often trade through analyst targets as institutional demand drives prices above consensus; the target may simply lag reality.

Per-dimension breakdown

Value

3.4/10data confidence 50%
ComponentSub-score
P/S2.0
EV/EBITDA0.0
Analyst target5.0

Quality

5.7/10data confidence 100%
ComponentSub-score
ROE1.3
ROA0.6
Gross margin3.8
Op margin7.5
Net margin6.0
Current ratio9.8
Moat6.4
Piotroski F10.0
  • ▸Strong Piotroski F-Score: 9/9

Growth

9.2/10data confidence 67%
ComponentSub-score
Rev growth10.0
EPS growth8.3
  • ▸Strong growth: 38% YoY

Momentum

5.5/10data confidence 100%
ComponentSub-score
RSI5.5
MACD2.6
OBV5.6
MA position4.0
Volume10.0
vol acceleration5.5
  • ▸Above 200-day MA

Sentiment

6.8/10data confidence 100%
ComponentSub-score
LLM sentiment5.8
Analyst rating7.5
Price target7.1

Insider

6.0/10data confidence 75%
ComponentSub-score
materiality5.0
holder change6.1
notable moves7.0
  • ▸Negligible insider buying — $2,407,650 (0.001% of mkt cap)

Peer rank

5.4/10data confidence 80%
ComponentSub-score
value rank0.8
quality rank5.0
growth rank8.0

Technical

6.6/10data confidence 100%
ComponentSub-score
bollinger6.5
support resistance5.9
52w position7.9
gap6.0

Risk (lower is worse)

5.8/10data confidence 100%
ComponentSub-score
short interest8.7
days to cover4.4
volatility5.8
put call0.0
implied vol7.8
max pain risk3.0
beta8.5
debt equity8.3
  • ▸Elevated put/call: 2.30
  • ▸Above max pain $145
  • ▸Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)

Catalyst

3.3/10data confidence 100%
ComponentSub-score
erm5.0
earnings history0.0
earnings timing5.0
surprise avg0.0
dividend safety2.0
news activity8.0
  • ▸Earnings concerns: 1B/3M

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (6)
  • MOMENTUM:5.5>=5.5
  • INSIDER:OK
  • 8K:CLEAN
  • EARNINGS_PROXIMITY:103d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • ASYMMETRY:0.6<1.5@spot
Warning (0)

none

Reward-to-Risk
0.57
Upside
+3.1%
Downside
5.4%
Sizing output
AVOID

SetupRange Bound — RSI 55 mid-range, Bollinger mid-band

EdgeNo clear edge — No clear edge identified

SuitabilityModerate — Balanced profile

Investment implication

The F-path SELL output reflects an overall score of 4.7 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Growth at 9.2) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:0.6<1.5@spot) reinforce the read. Current asymmetry R:R is 0.57 — supplementary context, not the trigger for this path.

The strongest dimensions are Growth at 9.2, Sentiment at 6.8, and Technical at 6.6; the weakest are Catalyst at 3.3, Value at 3.4, and Peer rank at 5.4. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of 0.57 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Seniors Housing Revenue Concentration

    Trip ifSeniors housing operating revenue contribution rises above 82% or same-store growth in that segment falls below 3% in any reported quarter.

  • P2Strong Revenue Growth Trajectory

    Trip ifYear-over-year revenue growth falls below 10% in at least 2 consecutive reported quarters.

  • P3Excellent Cash Conversion Quality

    Trip ifFree cash flow as a percentage of net income drops below 80% for at least 2 consecutive reported annual periods.

  • P4Price Target Exhaustion

    Trip ifPrice drops below $200, more than 6% below the current $212.82, without a corresponding analyst target increase of at least 8%.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home › Stocks › WELL › Why this verdict